Gene Query: TCEAL9

Dataset Description Geneva Score
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 73.88
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 39.19
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 35.93
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 35.93
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 35.69
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 33.7
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 32.69
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 32.54
ETV7 and interferon response 31.93
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 31.93
Global transcriptome analysis of HAP1 cells 29.01
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 28.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 28.91
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 28.36
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 27.75
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 27.3
Effect of Hotair overexpression in human breast cancer cell lines 26.7
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 26.07
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 26.01
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 24.8
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 24.77
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 24.77
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 23.41
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 23.41
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 22.99
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 22.51
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 22.41
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 21.8
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 20.69
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 20.49
Rorc disruption in human FG pancreatic cancer cells 20.42
Nucleoporin-mediated regulation of cell identity genes 20.05
Genome wide expression change by RNF168 knocking down in NEC cells 19.85
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 19.79
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 19.18
AR-independent prostate cancer is sustained through FGF signaling 19.1
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 19.04
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 19.04
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 18.86
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 18.62
MOF acetyl transferase regulates transcription and respiration in mitochondria 18.59
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 17.97
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 17.52
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 17.27
High-throughput sequencing of PROMPT-enriched samples. 17.21
Evolution of a transcriptional regulator from a transmembrane nucleoporin 17.18
RNA-seq in HepG2 and IMR90 cells 17.18
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 17.02
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 16.73
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 16.7
Disruption of the exocyst induces podocyte loss and dysfunction 16.44
Characterization of parental and rociletinib-resistant derived H1975 cell lines 16.41
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 16.41
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 16.28
RNA-seq of human fibroblasts after irradiation 16.25
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 16.18
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 16.18
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 16.15
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 15.99
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 15.82
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 15.6
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 15.47
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 15.46
Novel Targeting of Transcription and Metabolism in Glioblastoma 15.43
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 15.35
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 15.2
Global Mapping of Human RNA-RNA Interactions 15.08
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 15.07
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 14.86
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 14.76
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 14.75
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 14.7
Selective suppression of endothelial cytokine production by progesterone receptor 14.7
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 14.69
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 14.68
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 14.66
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 14.61
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 14.44
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 14.42
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 14.29
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 14.22
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 14.2
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 14.09
Global expression profiles in cardiac progenitor cells generated by ISX-9 14.09
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 13.96
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 13.9
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 13.88
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 13.8
FOXP1 orchestration of ASD-relevant signaling pathways. 13.79
Non-coding regions are the main source of tumor-specific antigens [human] 13.77
Non-coding regions are the main source of tumor-specific antigens 13.77
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 13.72
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 13.67
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 13.5
Transcriptome analysis in Neobractatin treated cells 13.43
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 13.42
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 13.39
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 13.32
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 13.32
WRN knockout effects upon gene expression in SW48 and OVK18 13.29
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 13.19
IDH3a KO RNA-seq 12.95
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 12.94
Differential analysis of gene regulation at transcript resolution by RNA-Seq 12.94
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 12.94
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 12.88
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 12.87
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 12.87
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 12.82
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 12.82
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 12.75
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 12.65
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 12.44
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 12.41
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 12.36
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 12.36
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.24
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 12.16
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 12.09
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 12.02
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 12.0
Identification of transcription start sites for human A549 cell line using ReCappable-seq 11.98
Differentiation enhances Zika virus infection in neuronal brain cells 11.97
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 11.96
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 11.94
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 11.94
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 11.94
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 11.93
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 11.84
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.8
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 11.72
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.7
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 11.51
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 11.42
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 11.35
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 11.35
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 11.33
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 11.2
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 11.11
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 11.06
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 11.03
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 10.97
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.96
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 10.94
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 10.88
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 10.86
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 10.85
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 10.81
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 10.8
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 10.8
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 10.79
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 10.79
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 10.74
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 10.71
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 10.7
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 10.61
RNA-seq in transgenic cells 10.6
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 10.59
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 10.59
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 10.59
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 10.54
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 10.52
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 10.51
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 10.47
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 10.47
Systematic discovery of endogenous human ribonucleoprotein complexes 10.46
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 10.46
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 10.45
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.44
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 10.42
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 10.38
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 10.34
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 10.34
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.33
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 10.33
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 10.32
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 10.26
Widespread regulated alternative splicing of single codons accelerates proteome evolution 10.2
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 10.2
Human cell line and subcutaneous tumor 10.18
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 10.13
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 10.13
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 10.12
Effect of disulfiram treatment on pediatric high grade glioma 10.09
EWSR1 influences alternative splicing through direct and indirect mechanisms 9.99
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 9.84
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 9.81
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 9.81
Region-specific Innate Antiviral Responses of the Human Epididymis 9.75
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 9.73
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.71
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 9.69
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 9.69
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 9.68
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.64
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 9.64
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 9.64
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 9.63
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.51
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 9.48
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.43
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 9.43
CDK4/6 inhibitor resistance in prostate cancer 9.41
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 9.41
A549 cells and MSR-A549 cells 9.41
RNA-seq of YB5 cells treated with Proscillaridin A 9.36
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 9.31
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 9.26
Cerebellar differentiation in Ataxia-Telangiectasia 9.22
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 9.22
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 9.21
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 9.13
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 9.08
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.07
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.07
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 9.02
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 9.02
Mutational landscape of splicing genes and functional consequences across 33 cancer types 8.97
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 8.95
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 8.9
Cell responses to dysregulated VZV-induced cell-cell fusion 8.88
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 8.82
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 8.72
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 8.71
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 8.7
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 8.68
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 8.67
Gene expression profile of human iPSC-derived nephron progenitor cells 8.64
RNA sequencing of GlyH-101-treated MCF-7 cell line 8.61
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 8.59
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 8.57
Transcriptome of U251 cells overexpression complement component 7 8.57
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.55
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.53
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 8.52
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 8.47
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 8.39
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 8.3
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 8.3
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 8.24
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 8.23
Biological effect of chronic mistranslation in mammalian cells 8.23
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 8.21
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 8.2
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.17
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 8.12
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 8.07
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 8.06
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 8.04
PNET animal model: new insights (II) 8.02
Molecular Mechanisms of Endothelial Hyperpermeability 7.97
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.92
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 7.91
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.9
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 7.83
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 7.82
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 7.81
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 7.79
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 7.78
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 7.77
RNA-seq of human aneuploid cell lines with Trisomy 21 7.69
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 7.69
BI Human Reference Epigenome Mapping Project 7.62
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 7.6
4sU-seq of HFF exposed to salt and heat stress 7.59
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 7.58
Mechanistic Model-Guided Study of Embryonic Morphogenesis 7.54
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 7.44
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 7.4
RNA editing in nascent RNA affects pre-mRNA splicing 7.36
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.36
Gene expression in GBM with Cav3.2 inhibition 7.34
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.34
Cleavage Factor Im as a key regulator of 3’ UTR length 7.3
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 7.3
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 7.26
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.25
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 7.22
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 7.19
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 7.18
Endothelial gene expression analysis 7.18
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 7.06
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 7.06
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 7.06
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 7.04
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.01
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.96
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 6.91
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 6.89
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 6.89
IMP3 regulated gene expression in breast cancer cells 6.86
STX4 Over-Expression in Human islets 6.85
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 6.84
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.81
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.8
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.73
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 6.67
iPSC derived motor neuron cultures from C9ORF72 carriers 6.63
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 6.6
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 6.58
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 6.56
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.55
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 6.33
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.26
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.25
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 6.21
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.13
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.12
Human HAP1 cells before and after nutrient deprivation 6.12
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 6.08
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 6.07
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 6.07
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 6.05
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 6.04
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.01
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 5.97
siRNA-mediated knockdown 5.91
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 5.84
Single cell transcriptome of peritoneal cells 5.81
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.8
HEK293 TFAM Knockout Expression Study 5.67
Molecular Criteria for Defining the Naive Human Pluripotent State 5.66
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.63
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 5.62
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 5.49
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.46
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 5.42
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 5.41
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 5.41
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 5.4
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.34
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 5.29
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.19
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.19
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.17
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.09
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 5.05
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.98
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.98
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 4.96
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 4.94
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.93
ARS2 is a general suppressor of pervasive transcription [RNAseq] 4.86
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 4.83
mRNA differential expression analysis in a human ex vivo model of chronic wounds 4.78
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 4.61
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.58
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.57
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 4.57
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 4.53
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 4.53
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 4.53
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.48
The bromodomain protein BRD4 regulates splicing during heat shock 4.41
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 4.4
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 4.39
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 4.38
A single cell reference map for human blood and tissue T cell activation 4.29
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.25
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 4.19
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.13
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 4.11
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 4.1
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 4.1
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.07
Analysis of transcriptional regulation by Myt1 and Myt1l 4.05
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.04
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.93
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.93
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.79
The Human Testis Cell Atlas via Single-cell RNA-seq 3.77
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.75
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 3.62
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.6
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 3.59
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.58
Metastasis in triple-negative breast cancer 3.58
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 3.57
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.56
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.52
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.49
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.49
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.47
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 3.42
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.35
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.31
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 3.23
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 3.17
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 3.17
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 3.16
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 3.14
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 3.14
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.11
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 3.05
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.02
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.98
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.97
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.96
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.93
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.9
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 2.84
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 2.73
Transcriptome of EBV-infected gastric cancer cell lines 2.7
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.67
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.67
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.62
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 2.59
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.58
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 2.55
Human ovarian granulosa cell transcriptome 2.51
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.42
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.42
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.41
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.37
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.36
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.35
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.27
Transcriptome sequencing of K-562 cells 2.26
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.26
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.25
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.18
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.05
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.97
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.96
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.96
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 1.93
RNA-Seq of PRMT1 overexpression ECA109 cells 1.88
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.87
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.84
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.84
Epigenomic conservation of transposable element silencing [RNA-seq] 1.79
Epigenomic conservation of transposable element silencing 1.79
Transcriptome-wide modulation of splicing by the exon junction complex 1.77
HBEC-shp53-PCHD7 1.73
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 1.71
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 1.7
Random mono-allelic expression in MECP2-mutated cells 1.69
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.68
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 1.66
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.64
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.62
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.61
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.61
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.61
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 1.58
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.58
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.54
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.49
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 1.46
Gene expression analysis in response to hypoxic pathway inhibition 1.46
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.45
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.45
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.43
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.39
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.39
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.37
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.35
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 1.31
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.3
A single-cell transcriptome atlas of the human pancreas 1.28
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.28
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.24
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.23
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.21
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.2
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.09
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.06
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.02
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.0
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.0
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.99
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.99
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.97
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.84
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.77
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.73
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.69
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.68
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.66
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.65
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.55
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.54
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.54
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.45
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.44
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.43
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.41
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.38
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.36
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.34
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.3
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.24
Transcriptional landscape changes during human embryonic stem cell derivation 0.12
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.11
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.11
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.11
RNA-seq of cancer cell lines treated with T-025 0.06
Modulation of nonsense-mediated decay by rapamycin 0.05
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.05
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation